Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 193
Healthy volunteers: yes

Brief summary:
This trial will investigate the pharmacokinetics, safety and tolerability of BI 695501 and to establish pharmacokinetic equivalence of BI 695501 to adalimumab.

Detailed description:

Arms:
arm 1: Subject to receive one subcutaneous (s.c.) injection from a prefilled syringe containing BI 695501 arm 2: Subject to receive one s.c. injection from a prefilled syringe containing 40mg adalimumab arm 3: Subject to receive one s.c. injection from a prefilled syringe containing 40mg adalimumab

Interventions: intervention 1: adalimumab intervention 2: BI695501 intervention 3: adalimumab
Intervention descriptions: intervention 1: 40mg adalimumab single s.c. injection intervention 2: BI 695501 single s.c injection intervention 3: 40mg adalimumab single s.c. injection

Protocol document: